Price Chart

Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.98% 0.05% 5.575M 4157.57
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
-- -- --

Basic Info

Investment Strategy
The Fund seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Top 5 Equal Weight Index. The return for investors that invest for periods longer or shorter than a trading day should not be expected to be 200% of the performance of the Index for the period.
General
Security Type Exchange-Traded Fund
Equity Style --
Broad Asset Class Miscellaneous
Broad Category Alternative Strategies
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
--
--
--
--
--
--
44.67%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
17.88%
13.00%
30.15%
-3.22%
40.41%
-41.12%
62.10%
65.14%
37.06%
-11.62%
--
--
--
--
--
--
--
-44.17%
--
--
--
--
--
--
--
65.54%
--
--
--
--
--
--
--
75.55%
As of August 26, 2026.

Asset Allocation

As of July 31, 2026.
Type % Net
Cash 13.00%
Stock 39.44%
Bond 43.87%
Convertible 0.00%
Preferred 0.00%
Other 3.69%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Top 5 Equal Weight Index. The return for investors that invest for periods longer or shorter than a trading day should not be expected to be 200% of the performance of the Index for the period.
General
Security Type Exchange-Traded Fund
Equity Style --
Broad Asset Class Miscellaneous
Broad Category Alternative Strategies
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders